Sequencing (Whole Genomic and RNA-seq)

The Food and Drug Administration is forecasting a requirement for Whole Genomic and RNA-seq sequencing services. This priority 2 initiative is managed by the agency's CBER acquisitions team, though a specific contracting officer has not yet been assigned. The opportunity is currently listed as a forecast, and further details regarding the NAICS code, set-aside status, and place of performance are pending. Interested parties can coordinate through the CBER Acquisition Liaison for additional information.